Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Equity (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Return on Equity for 14 consecutive years, with 0.55% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 5.0% to 0.55% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.55% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.59% for FY2025, 3.0% up from the prior year.
  • Return on Equity hit 0.55% in Q4 2025 for Guided Therapeutics, up from 0.47% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.73% in Q2 2023 to a low of 0.27% in Q2 2021.
  • Historically, Return on Equity has averaged 0.66% across 5 years, with a median of 0.49% in 2025.
  • Biggest five-year swings in Return on Equity: surged 139bps in 2023 and later crashed -123bps in 2024.
  • Year by year, Return on Equity stood at 0.29% in 2021, then skyrocketed by 437bps to 1.57% in 2022, then plummeted by -40bps to 0.94% in 2023, then plummeted by -47bps to 0.49% in 2024, then grew by 11bps to 0.55% in 2025.
  • Business Quant data shows Return on Equity for GTHP at 0.55% in Q4 2025, 0.47% in Q3 2025, and 0.48% in Q2 2025.